ÉCOBES - Recherche et transfert, Cégep de Jonquière, Saguenay, QC, Canada.
Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN), Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-St-Jean, Saguenay, QC, Canada.
J Neuromuscul Dis. 2022;9(5):629-639. doi: 10.3233/JND-221503.
Myotonic dystrophy type 1 (DM1) is a multisystemic neuromuscular disorder causing a plea of impairments, of which fatigue and apathy are some of the most frequent non-muscular symptoms. No curative treatment exists to date, and patients only have access to limited effective care, which are intended to decrease the burden of specific symptoms in daily life.
This study aimed to assess whether a 12-week strength training program has an impact on fatigue/daytime sleepiness, apathy, and disease bruden in men with DM1.
Eleven participants completed the Fatigue and Daytime Sleepiness Scale (FDSS) and the Myotonic Dystrophy Health Index (MDHI) at baseline, at 6 and 12 weeks, and at 6 and 9 months. Also, the Apathy Evaluation Scale (AES) was filled out at baseline, at 12 weeks, and at 6 and 9 months.
Results show significant effects of the training program both on apathy and fatigue/daytime sleepiness, effects that are respectively greater at three and six months after the end of the program than at its very end. However, no difference was observed regarding the overall disease burden.
These findings are promising for patients with DM1 considering that few non-pharmacological treatments are available.
1 型肌强直性营养不良(DM1)是一种多系统神经肌肉疾病,导致多种功能障碍,其中疲劳和淡漠是最常见的非肌肉症状之一。迄今为止尚无治愈方法,患者只能获得有限的有效治疗,这些治疗旨在减轻日常生活中特定症状的负担。
本研究旨在评估 12 周的力量训练计划是否会对男性 DM1 患者的疲劳/日间嗜睡、淡漠和疾病负担产生影响。
11 名参与者在基线时、6 周和 12 周以及 6 个月和 9 个月时完成了疲劳和日间嗜睡量表(FDSS)和肌强直性营养不良健康指数(MDHI)。此外,在基线时、12 周时以及 6 个月和 9 个月时填写了淡漠评估量表(AES)。
研究结果表明,训练计划对淡漠和疲劳/日间嗜睡均有显著影响,这些影响在计划结束后三个月和六个月时比在计划结束时更大。然而,在总体疾病负担方面没有差异。
这些发现对 DM1 患者来说是有希望的,因为几乎没有非药物治疗方法。